Safer, smarter, multimodal generative AI agents for personalized healthcare — delivering precise insights, predictive care, cardiovascular digital therapeutics, and enterprise-grade automation for patients, clinicians, and health systems.
Personalized, generative AI medical chatbot with specialist modules, medical image analysis, voice interaction, and personal risk predictions. HIPAA, GDPR compliant.
Comprehensive, personalized risk predictions for the onset or recurrence of cardiovascular and oncology conditions, with actionable mitigation strategies.
Physician-led, AI-supported therapeutics for chronic cardiovascular conditions, with remote monitoring, patient empowerment, and proactive clinician oversight.
Designed for patients and healthcare providers, it offers accurate information on symptoms and health queries, based on approved guidelines. Effectively manage chronic conditions with specialized modules like Oncology AI, Cardiovascular AI, skin analysis with Dermatology AI, and diagnostic imaging with Radiology AI.
We offer a modular catalogue of production-grade AI agents that automate and augment tasks across the care continuum using chats, voice, and images — from intake and chronic care outreach to screening programs, and safety surveillance.
A next-generation digital therapeutics app-on-prescription, powered by generative AI and predictive analytics, and paired with a Chronic Care Monitor designed for cardiologists. Now entering the final phase of clinical validation and MDR IIb approval.
Learn more
AI-assisted remote patient monitoring with predictive analytics, helping providers set up, monitor, and optimize personalized care plans. Customizable for unique needs in clinical practice and research.
We help healthcare and life science leaders identify high-value AI opportunities, craft responsible adoption roadmaps, and deliver custom co-developments that turn vision into measurable outcomes.
A next-generation, personalized cardiac digital twin for interventional planning, multimodal predictive analytics, and management of comorbidities in chronic heart-failure patients.
Currently in research and co-development with leading clinical and academic partners.
2025 - All Rights Reserved.